Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial

IMPORTANCE: Intense interest exists in novel ω-3 formulations with high bioavailability to reduce blood triglyceride (TG) levels. OBJECTIVE: To determine the phase 3 efficacy and safety of a naturally derived krill oil with eicosapentaenoic acid and docosahexaenoic acid as both phospholipid esters (...

Descripción completa

Detalles Bibliográficos
Autores principales: Mozaffarian, Dariush, Maki, Kevin C., Bays, Harold E., Aguilera, Fernando, Gould, Glenn, Hegele, Robert A., Moriarty, Patrick M., Robinson, Jennifer G., Shi, Peilin, Tur, Josefina F., Lapointe, Jean-François, Aziz, Sarya, Lemieux, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739762/
https://www.ncbi.nlm.nih.gov/pubmed/34989797
http://dx.doi.org/10.1001/jamanetworkopen.2021.41898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739762/
https://www.ncbi.nlm.nih.gov/pubmed/34989797
http://dx.doi.org/10.1001/jamanetworkopen.2021.41898

Ejemplares similares